ATP (plasma) in ME/CFS

ATP (plasma), also described as Adenosine triphosphate — LC overlap, belongs to the metabolic group of ME/CFS (ME/CFS, CFS) markers and is reported to be decreased relative to healthy controls. The cited literature links this alteration to energy deficit. The finding is drawn from Saito et al. 2024; it describes group-level differences, not a threshold that classifies an individual.

↓ ReducedMetabolic

Summary

Direction in ME/CFS↓ Reduced — lower than in the comparison group
CategoryMetabolic
Also described asAdenosine triphosphate — LC overlap
Compared againstHC (healthy controls)
Associated symptomsEnergy deficit
Test typeBlood test (serum / plasma / whole blood)
SourceSaito et al. 2024 — doi:10.3389/fimmu.2024.1341843
Condition atlasME/CFS Biomarker Atlas

Other conditions where ATP (plasma) is reported

See the cross-condition hub: ATP (plasma) across conditions.

Related Metabolic markers in ME/CFS

Full list: ME/CFS Biomarker Atlas.

Frequently asked questions

Is ATP (plasma) high or low in ME/CFS?

Reduced. Studies summarised in the OSMF atlas report lower ATP (plasma) in ME/CFS than in healthy controls. Source: Saito et al. 2024.

What symptoms is ATP (plasma) associated with in ME/CFS?

The cited literature associates this marker with Energy deficit. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures ATP (plasma)?

It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal ATP (plasma) result diagnostic of ME/CFS?

No. No single biomarker is diagnostic of ME/CFS. ATP (plasma) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is ATP (plasma) specific to ME/CFS?

No. The same marker is also reported in Long COVID in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). ATP (plasma) in ME/CFS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/me-cfs/atp-plasma.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from me-cfs.json · Browse: ME/CFS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.